
TriMas Corporation (NASDAQ:TRS - Free Report) - Zacks Research increased their FY2025 earnings per share estimates for TriMas in a report released on Thursday, September 4th. Zacks Research analyst Team now forecasts that the industrial products company will post earnings of $2.02 per share for the year, up from their prior forecast of $2.00. Zacks Research currently has a "Strong-Buy" rating on the stock. The consensus estimate for TriMas' current full-year earnings is $1.69 per share. Zacks Research also issued estimates for TriMas' Q4 2025 earnings at $0.39 EPS, Q2 2026 earnings at $0.69 EPS, Q3 2026 earnings at $0.62 EPS, Q4 2026 earnings at $0.50 EPS, FY2026 earnings at $2.32 EPS, Q2 2027 earnings at $0.70 EPS and FY2027 earnings at $2.36 EPS.
Other equities research analysts have also recently issued research reports about the company. BWS Financial reissued a "buy" rating and issued a $45.00 price target (up previously from $40.00) on shares of TriMas in a research note on Wednesday, July 30th. Wall Street Zen upgraded shares of TriMas from a "hold" rating to a "buy" rating in a research note on Sunday, June 1st. Finally, KeyCorp set a $45.00 price target on TriMas and gave the company an "overweight" rating in a research report on Tuesday, August 12th. One equities research analyst has rated the stock with a Strong Buy rating and two have assigned a Buy rating to the company's stock. According to data from MarketBeat, TriMas presently has a consensus rating of "Buy" and an average price target of $45.00.
Check Out Our Latest Research Report on TriMas
TriMas Price Performance
Shares of TRS traded up $0.37 during midday trading on Friday, hitting $39.10. The company's stock had a trading volume of 761,132 shares, compared to its average volume of 534,913. TriMas has a one year low of $19.33 and a one year high of $39.71. The company's fifty day simple moving average is $34.35 and its two-hundred day simple moving average is $27.69. The company has a quick ratio of 1.44, a current ratio of 2.59 and a debt-to-equity ratio of 0.59. The stock has a market capitalization of $1.59 billion, a price-to-earnings ratio of 42.97 and a beta of 0.65.
TriMas (NASDAQ:TRS - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The industrial products company reported $0.61 EPS for the quarter, topping analysts' consensus estimates of $0.50 by $0.11. The company had revenue of $274.76 million for the quarter, compared to analyst estimates of $251.18 million. TriMas had a return on equity of 11.49% and a net margin of 3.83%.TriMas's revenue was up 14.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.43 earnings per share. TriMas has set its FY 2025 guidance at 1.950-2.100 EPS.
Hedge Funds Weigh In On TriMas
A number of institutional investors have recently bought and sold shares of TRS. Price T Rowe Associates Inc. MD raised its holdings in TriMas by 10.7% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 27,993 shares of the industrial products company's stock valued at $689,000 after acquiring an additional 2,703 shares during the period. Northern Trust Corp grew its stake in TriMas by 9.9% in the fourth quarter. Northern Trust Corp now owns 398,213 shares of the industrial products company's stock worth $9,792,000 after purchasing an additional 35,798 shares in the last quarter. Bank of America Corp DE increased its holdings in shares of TriMas by 127.3% in the 4th quarter. Bank of America Corp DE now owns 3,513,638 shares of the industrial products company's stock valued at $86,400,000 after acquiring an additional 1,967,738 shares during the period. Cubist Systematic Strategies LLC purchased a new stake in TriMas during the fourth quarter valued at approximately $883,000. Finally, Deutsche Bank AG lifted its holdings in shares of TriMas by 45.6% during the 4th quarter. Deutsche Bank AG now owns 36,305 shares of the industrial products company's stock valued at $893,000 after purchasing an additional 11,363 shares during the last quarter. 99.42% of the stock is owned by institutional investors.
TriMas Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, August 12th. Stockholders of record on Tuesday, August 5th were issued a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a dividend yield of 0.4%. The ex-dividend date of this dividend was Tuesday, August 5th. TriMas's dividend payout ratio is presently 17.58%.
About TriMas
(
Get Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Featured Articles

Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.